# Treatment With Crizotinib Single Patient Expanded Access IND 134375

> **NCT03085186** · — · NO_LONGER_AVAILABLE · sponsor: **Jean M. Tersak, M.D.**

## Conditions studied

- Inflammatory Myofibroblastic Tumour

## Interventions

- **DRUG:** Crizotinib

## Key facts

- **NCT ID:** NCT03085186
- **Lead sponsor:** Jean M. Tersak, M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085186, "Treatment With Crizotinib Single Patient Expanded Access IND 134375". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03085186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*